Search

Your search keyword '"Metabotropic glutamate receptors"' showing total 1,267 results

Search Constraints

Start Over You searched for: Descriptor "Metabotropic glutamate receptors" Remove constraint Descriptor: "Metabotropic glutamate receptors"
1,267 results on '"Metabotropic glutamate receptors"'

Search Results

1. SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms.

2. Alpha-secretase inhibition impairs Group I metabotropic glutamate receptor-mediated protein synthesis, long-term potentiation and long-term depression.

5. Post-stress Social Interaction and 3-Cyano-N-(1,3-Diphenyl-1H-Pyrazol-5-yl) Benzamide Treatment Attenuate Depressive-like Behavior Induced by Repeated Social Defeat Stress.

6. Group 1 metabotropic glutamate receptor expression defines a T cell memory population during chronic Toxoplasma infection that enhances IFN-gamma and perforin production in the CNS.

7. Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders

8. Phenibut, Semax, and GIZh-290 Modulate Cortical mGluII Receptors in an Attention Deficit Model in Mice.

11. CRISPR-mediated activation of autism gene Itgb3 restores cortical network excitability via mGluR5 signaling

12. Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders.

13. Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.

14. Group I Metabotropic Glutamate Receptors Modulate Motility and Enteric Neural Activity in the Mouse Colon.

15. The influence of glutamate receptors on insulin release and diabetic neuropathy.

16. Red nucleus mGluR2 but not mGluR3 mediates inhibitory effect in the development of SNI-induced neuropathological pain by suppressing the expressions of TNF-α and IL-1β.

17. Red nucleus mGluR1 and mGluR5 facilitate the development of neuropathic pain through stimulating the expressions of TNF-α and IL-1β.

19. Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu 5 Receptors.

20. X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer's disease.

21. Features of the Effects of Glutamatergic System Modulators in the Model of Hyperthermal Seizures in Rat Pups.

22. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.

23. mGlu2 mechanism-based interventions to treat alcohol relapse.

24. Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

25. mGlu2 mechanism-based interventions to treat alcohol relapse

26. Researchers at Yale University School of Medicine Report New Data on Marijuana/Cannabis (Metabotropic Glutamate Receptor 5 As a Potential Biomarker of the Intersection of Trauma and Cannabis Use).

27. Researchers at Yale University School of Medicine Report New Data on Marijuana/Cannabis.

29. Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.

30. Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

31. Group II metabotropic glutamate receptor (mGlu2 and mGlu3) roles in thalamic processing.

32. Orai1 is a crucial downstream partner of group I metabotropic glutamate receptor signaling in dorsal horn neurons.

33. Group I mGluRs in Therapy and Diagnosis of Parkinson's Disease: Focus on mGluR5 Subtype.

34. Ionotropic glutamate receptors and their implications in cancer and cancer therapeutics

35. Regulation of Metabotropic Glutamate Receptor Internalization and Synaptic AMPA Receptor Endocytosis by the Postsynaptic Protein Norbin.

36. Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons.

37. Glutamate receptors and glutamatergic signalling in the peripheral nerves

38. Group I Metabotropic Glutamate Receptors Modulate Motility and Enteric Neural Activity in the Mouse Colon

39. Group I metabotropic glutamate receptors (mGluR1/5) and neurodegenerative diseases

40. Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons

41. Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice.

42. Heterodimers Revolutionize the Field of Metabotropic Glutamate Receptors.

43. Isolation housing elevates amphetamine seeking independent of nucleus accumbens glutamate receptor adaptations.

44. Loss of mGluR1-LTD following cocaine exposure accumulates Ca2+-permeable AMPA receptors and facilitates synaptic potentiation in the prefrontal cortex.

45. Group I Metabotropic Glutamate Receptors (mGluRs): Ins and Outs

46. Reports from Tehran University of Medical Sciences Advance Knowledge in Pruritus ["Niclosamide: A potential antipruritic agent by modulating serotonin pathway through metabotropic glutamate receptors (mGluRs)"].

47. Researchers Submit Patent Application, "Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Anorexia Nervosa And Binge Eating Disorder", for Approval (USPTO 20240189295).

48. Findings from Vanderbilt University Has Provided New Data on Cognitive Disorders (Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators In Cognitive Disorders).

49. Patent Application Titled "Methods Of Diagnosing And Treating Adhd In Biomarker Positive Subjects" Published Online (USPTO 20240156801).

50. Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu5 Receptors

Catalog

Books, media, physical & digital resources